Cabergoline: a long-acting dopamine agonist in Parkinson's disease

Ann Neurol. 1990 Oct;28(4):593-4. doi: 10.1002/ana.410280429.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Oral
  • Antiparkinson Agents / pharmacokinetics
  • Antiparkinson Agents / pharmacology
  • Antiparkinson Agents / therapeutic use*
  • Cabergoline
  • Drug Evaluation
  • Drug Therapy, Combination
  • Ergolines / administration & dosage
  • Ergolines / pharmacokinetics
  • Ergolines / therapeutic use*
  • Humans
  • Levodopa / administration & dosage
  • Levodopa / therapeutic use
  • Parkinson Disease / drug therapy*
  • Receptors, Dopamine / drug effects

Substances

  • Antiparkinson Agents
  • Ergolines
  • Receptors, Dopamine
  • Levodopa
  • Cabergoline